Thai Cannabis Firm Iridescent Med Plans Clean Energy Plant to Boost Production

By Thailand THC



thailandTHC > News > Thai Cannabis Firm Iridescent Med Plans Clean Energy Plant to Boost Production

Last updated on June 24th, 2024 at 10:13 am

  • Why It Matters: Sustainable practices in cannabis production can significantly reduce environmental impact.
  • Driving The News: Iridescent Med, a leading Thai medical cannabis producer, announces plans for a new clean energy-powered facility.
  • The Big Picture: The company’s expansion highlights the growing medical cannabis industry and the shift towards eco-friendly manufacturing.

BANGKOK, THAILAND – Iridescent Med, a major player in Thailand’s medical cannabis industry, is set to revolutionize the market with its plans to build a new clean energy-powered facility. The company, known for its comprehensive approach to medical cannabis production, aims to reduce its carbon footprint while increasing its production capacity.

IRIDESCENT MED, a European-standard producer of medical cannabis, provides OEM production services from cultivation to finished products. The company’s product range includes cannabis flowers, CBD cosmetics, and CBD supplements, all produced under stringent GACP international standards. Their products are available both domestically and internationally.

In a statement, CEO MIN-SIRATCHA PHATCHARASOPHACHAI emphasized the company’s commitment to high-quality production and sustainable practices. The new facility, to be built with a 500-million-baht investment in Chonburi province, will utilize clean energy from the company’s affiliated power plants. This move is expected to significantly lower carbon emissions and enhance the company’s competitive edge in the global market.

Iridescent Med collaborates with top research institutions and experts from the United States on various medical cannabis research projects. Their state-of-the-art cultivation methods, including sterile grow rooms and tailored nutrient regimens, ensure high-purity cannabis with minimal contaminants, suitable for medical use and export.

The company’s offerings are divided into three main categories:

  1. Medical-grade cannabis flowers for legal export.
  2. CBD cosmetics, including skincare products, therapeutic oils, and pain relief gels.
  3. CBD dietary supplements like health gummies and sublingual oils.

Iridescent Med’s strategic expansion into clean energy-powered production facilities aligns with the growing demand for sustainable practices in the cannabis industry. By 2026, the company aims to be Asia’s leading exporter of high-quality medical cannabis, with consistent yields and environmentally friendly operations.

Contributing Sources: Newswit

.